Long-term consequences of estrogen and estrogen-progestin replacement

[1]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[2]  R. Bergström,et al.  Women with climacteric symptoms: A target group for prevention of rapid bone loss and osteoporosis , 1992, Osteoporosis International.

[3]  H. Adami,et al.  Cohort study of oestrogen treatment and the risk of endometrial cancer: Evaluation of method and its applicability , 1983, European Journal of Clinical Pharmacology.

[4]  H. Adami,et al.  Cause‐Specific Mortality in Women Receiving Hormone Replacement Therapy , 1997, Epidemiology.

[5]  E. Eaker,et al.  The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement , 1992, British journal of obstetrics and gynaecology.

[6]  S. Thacker,et al.  A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. , 1991, JAMA.

[7]  S. Thacker,et al.  A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer , 1991 .

[8]  G. Colditz,et al.  Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆ , 1991 .

[9]  R. Hoover,et al.  Survival in women receiving hormone replacement therapy. A record-linkage study of a large population-based cohort. , 1991, Journal of clinical epidemiology.

[10]  W. Willett,et al.  Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. , 1990, JAMA.

[11]  H. Adami,et al.  Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. , 1990, Annals of internal medicine.

[12]  R. Hoover,et al.  The Risk of Breast Cancer after Estrogen and Estrogen-Progestin Replacement , 1990 .

[13]  Persson Ingemar,et al.  Survival in women receiving hormone replacement therapy. A record-linkage study of a large population-based cohort. , 1990 .

[14]  R. Hoover,et al.  Risk of cancer in women receiving hormone replacement therapy , 1989, International journal of cancer.

[15]  R. Hoover,et al.  The risk of breast cancer after estrogen and estrogen-progestin replacement. , 1989, The New England journal of medicine.

[16]  H. Adami,et al.  PROGNOSIS AFTER BREAST CANCER DIAGNOSIS IN WOMEN EXPOSED TO ESTROGEN AND ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY , 1989 .

[17]  R. Hoover,et al.  Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. , 1989, BMJ.

[18]  M. Pike,et al.  The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. , 1988, European journal of cancer & clinical oncology.

[19]  K. McPherson,et al.  Long‐term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy , 1988, British journal of obstetrics and gynaecology.

[20]  S. Sidney,et al.  Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. , 1987, Obstetrics and gynecology.

[21]  M. Coleman,et al.  Long‐term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy , 1987 .

[22]  I Persson,et al.  The relation between survival and age at diagnosis in breast cancer. , 1986, The New England journal of medicine.

[23]  H. Adami,et al.  Climacteric Symptoms and Estrogen Replacement Therapy In Women with Endometrial Carcinoma , 1986, Acta obstetricia et gynecologica Scandinavica.